FOXO1 and obesity due to melanocortin 4 receptor deficiency: FOXO1 inhibits skeletal muscle growth and protein synthesis by inhibiting the activity of essential anabolic pathways, such as mTORC1, leading to muscle wasting and impaired glucose metabolism in obesity.